The Lions Eye Institute (LEI) has signed a commercial partnership that will combine its antisense gene therapy for a leading cause of childhood blindness with a new Australian-developed drug delivery platform. Read more
UTS Orthoptics opens new facility
The University of Technology Sydney’s (UTS) orthoptics department celebrated the opening of its new purpose-built facilities with a clinician’s evening last week. Read more
SOVS Head of School portrait unveiled
The University of New South Wales’ School of Optometry and Vision Science (SOVS) has continued its long-standing tradition of the honouring former heads of school with an academic portrait. Read more
BHVI divisions announce new leadership changes
The Brien Holden Vision Institute (BHVI) has announced new appointments in the public health and science divisions of the organisation. Read more
Victorian eye hospital establishes new orthoptist-led cataract clinic
A new clinic led by upskilled orthoptists is helping the Royal Victorian Eye and Ear Hospital (RVEEH) reduce wait times and streamline follow up appointments for cataract patients. Read more
MDFA releases $600,000 in new grants to tackle macular disease
The Macular Disease Foundation Australia (MDFA) has awarded $600,000 in new research grants to advance research into Indigenous diabetic vision loss, sub-retinal fibrosis and novel disease detection methods. Read more
Aussie tear test could diagnose diabetes complication
A potential biomarker located in the eye for a debilitating complication of diabetes could be the key to future development of a new point-of-care screening device. Read more
Australia wins bid for 2021 World Congress of Optometry
Optometry Victoria South Australia (OV/SA) and the Optical Distributors & Manufacturers Association (ODMA) have secured hosting rights for the 4th World Congress of Optometry in 2021. The groups plan to run the event in conjunction with the country’s premiere optical show, O=MEGA. Read more
Jetrea eye injection receives new PBS listing
A new formulation of the Jetrea intravitreal injection has been listed on Pharmaceutical Benefits Scheme (PBS), replacing the current powder form of the drug. Read more
Aussie-developed dry eye device to hit market within five years
An Australian optometrist is spearheading efforts to develop the world’s first point-of-care test that can both diagnose and subtype dry eye disease. Read more